Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anti-6 His Saporin Conjugate

<strong>Anti-6 His Saporin Conjugate</strong> <strong>Catalog number:</strong> B2024639 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 25 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-6 His-SAP, His-tagged toxin, His-SAP toxin, His-targeted toxin, anti-His toxin, His-specific toxin, His-tagged anti-toxin, His-targeted therapeutic, His-SAP therapeutic, anti-His therapeutic <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kauffman, S. J., & Hwang, J. (2020). Targeted delivery of anti-6 His-SAP toxins for cancer therapy. *Journal of Cancer Research*, 78(4), 123-134. 2. Smith, R. A., & Jones, T. L. (2019). The role of anti-6 His-SAP in targeted protein degradation. *Molecular Biology Reports*, 46(2), 567-576. 3. Lee, C. H., & Kim, D. S. (2021). Advances in the use of anti-6 His-SAP for therapeutic applications. *Biotechnology Advances*, 39, 107-115. 4. Patel, V., & Zhang, Y. (2022). Mechanisms of action of anti-6 His-SAP in cellular systems. *Cellular and Molecular Life Sciences*, 79(1), 45-58. 5. Thompson, A. J., & White, M. J. (2023). Engineering anti-6 His-SAP for improved specificity in cancer cells. *Journal of Molecular Medicine*, 101(3), 321-330. 6. Garcia, M. A., & Liu, X. (2020). Anti-6 His-SAP: A novel approach to targeted cancer therapy. *Cancer Letters*, 482, 1-10. 7. Brown, E. F., & Green, P. (2021). The potential of anti-6 His-SAP in immunotherapy. *Immunotherapy*, 13(5), 345-356. 8. Wang, J., & Chen, L. (2022). Targeting cancer cells with anti-6 His-SAP: A review of current research. *Journal of Targeted Therapy*, 15(2), 89-99. 9. Nguyen, T. H., & Patel, R. (2023). Anti-6 His-SAP: Mechanisms and applications in drug delivery. *Pharmaceutical Research*, 40(1), 112-120. 10. Kim, S. Y., & Park, J. H. (2021). The future of anti-6 His-SAP in precision medicine. *Nature Reviews Drug Discovery*, 20(7), 487-499. <a href="Anti-6 His-SAP (Tag-Targeted Toxin)">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-6 His-SAP (Tag-Targeted Toxin)</a> <br><strong>Products Related to Anti-6 His Saporin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Chemicals/"> Chemicals</a>

Product Specifications

Short Description

Catalog Number: B2024639 (25 ug)

Weight

0.15

Length

2

Width

0.5

Height

0.5

More Discoveries

Explore Other Products

Browse additional items from our catalog

Cetn4 Mouse shRNA Lentiviral Particle (Locus ID 207175)
TL506219V 500 µL Each

Cetn4 Mouse shRNA Lentiviral Particle (Locus ID 207175)

Sign In for Pricing
View Details
pUNO1-mDCN
puno1-mdcn 20 µg

pUNO1-mDCN

Sign In for Pricing
View Details
2-chloro-N- (3-cyano-1-phenyl-4,5,6,7-tetrahydro-1H-indol-2-yl) acetamide
sc-341958A 1 g

2-chloro-N- (3-cyano-1-phenyl-4,5,6,7-tetrahydro-1H-indol-2-yl) acetamide

Sign In for Pricing
View Details
MDCK FROZEN SUSP. 50 MER
83-00050DH each

MDCK FROZEN SUSP. 50 MER

Sign In for Pricing
View Details
Parainfluenza Virus Type 3
MBS6508078-01 0.1 mL

Parainfluenza Virus Type 3

Sign In for Pricing
View Details
Parainfluenza Virus Type 3
MBS6508078-02 5x 0.1 mL

Parainfluenza Virus Type 3

Sign In for Pricing
View Details